Read Trending Stories
- » Are Facebook Losses Bigger Than Initially Thought?
- » Consumer Business Recap: Toyota Needs Emerging Markets, Wal-Mart's Express Update
- » Consumer Biz Recap: Talbots CRASHES HARD, Time Warner Eyes Sports Website
- » Your Cheat Sheet to Apple's Week of Stock Moving News
- » AOL and 2 Media Titans Making Waves
Today's Trending Stocks
Click a Company to Research Now:
- Bank of America (BAC)
- Apple . (AAPL)
- Facebook (FB)
- AT&T (T)
- Nokia (NOK)
- Delcath Systems (DCTH)
- Mentor Graphics Corp (MENT)
- Complete Genomics (GNOM)
Polypore International Inc.(NYSE:PPO): Needham believes LG Chem’s announcement that it will produce separators is likely to have minimal financial impact to Polypore since the material will be used in consumer electronic devices and not electric vehicles. The firm views yesterday’s sell-off in Polypore shares as creating a good buying opportunity and reiterates a Strong Buy rating on the stock.
Amazon.com Inc.(NASDAQ:AMZN): Amazon.com price target lowered to $182 from $190 at Goldman.
PerkinElmer Inc.(NYSE:PKI): Goldman continues to see upside to FY12 estimates and believes the company’s transformation is under-appreciated. Shares are Buy rated with a $31 price target, up from $27.
Medivation, Inc.(NASDAQ:MDVN): Wedbush raised its estimates and price target for Medivation after the company reported positive AFFIRM results. The firm believes the results confirm MDV3100′s promise as a treatment for prostate cancer and keeps an Outperform rating on the stock.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.
To contact the reporter on this story: Derek Hoffman at staff.writers@wallstcheatsheet.com
To contact the editor responsible for this story: Damien Hoffman at editors@wallstcheatsheet.com
Get Your FREE Special Report: 4 Things You Must Know About the US Economy Now!
Do You Want More Profits? Wall St. Cheat Sheet Premium newsletter subscribers have been crushing the markets with winning stock picks.
Click here now for your FREE trial to our acclaimed flagship newsletter:
